Literature DB >> 15309119

Upregulation of Multidrug Resistance Transporters in the Epileptic Brain.

Helen Scharfman.   

Abstract

Entities:  

Year:  2002        PMID： 15309119      PMCID： PMC321147          DOI： 10.1111/j.1535-7597.2002.00076.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.872


× No keyword cloud information.
  6 in total

1.  Multidrug-resistance protein 1 in focal cortical dysplasia.

Authors:  S M Sisodiya; W R Lin; M V Squier; M Thom
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

2.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

Authors:  R L Juliano; V Ling
Journal:  Biochim Biophys Acta       Date:  1976-11-11

3.  Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy.

Authors:  A Lazarowski; G Sevlever; A Taratuto; M Massaro; A Rabinowicz
Journal:  Pediatr Neurol       Date:  1999-10       Impact factor: 3.372

4.  Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.

Authors:  S M Dombrowski; S Y Desai; M Marroni; L Cucullo; K Goodrich; W Bingaman; M R Mayberg; L Bengez; D Janigro
Journal:  Epilepsia       Date:  2001-12       Impact factor: 5.864

5.  MDR1 gene expression in brain of patients with medically intractable epilepsy.

Authors:  D M Tishler; K I Weinberg; D R Hinton; N Barbaro; G M Annett; C Raffel
Journal:  Epilepsia       Date:  1995-01       Impact factor: 5.864

6.  Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance.

Authors:  Massimo Rizzi; Silvio Caccia; Giovanna Guiso; Cristina Richichi; Jan A Gorter; Eleonora Aronica; Marisa Aliprandi; Renzo Bagnati; Roberto Fanelli; Maurizio D'Incalci; Rosario Samanin; Annamaria Vezzani
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167
  6 in total
  1 in total

1.  Synthesis, Modelling, and Anticonvulsant Studies of New Quinazolines Showing Three Highly Active Compounds with Low Toxicity and High Affinity to the GABA-A Receptor.

Authors:  Mohamed F Zayed; Saleh K Ihmaid; Hany E A Ahmed; Khaled El-Adl; Ahmed M Asiri; Abdelsattar M Omar
Journal:  Molecules       Date:  2017-01-24       Impact factor: 4.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.